Friday, November 22, 2024
HomeTagsMultiple organ systems

multiple organ systems

FDA Approves AYVAKIT as the First and Only Treatment for Indolent Systemic Mastocytosis

Blueprint Medicines Corporation announced that the U.S. Food and Dru Administration (FDA) has approved AYVAKIT (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM)....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics